doi:10.1007/s12250-019-00111-6

Ackermann M, Braun DK, Pereira L, Roizman B, 1984: Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies[J]. J Virol, 52, 108-118.
Aranda AM, Epstein AL, 2015: Herpes simplex virus type 1 latency and reactivation: an update[J]. Med Sci (Paris), 31, 506-514. doi: 10.1051/medsci/20153105012
Bloom DC, 2016: Alphaherpesvirus latency: a dynamic state of transcription and reactivation[J]. Adv Virus Res, 94, 53-80. doi: 10.1016/bs.aivir.2015.10.001
Carter CJ, 2011: Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction[J]. Neurochem Int, 58, 301-320. doi: 10.1016/j.neuint.2010.12.003
Cui C, Griffiths A, Li G, Silva LM, Kramer MF, Gaasterland T, 2006: Prediction and identification of herpes simplex virus 1-encoded microRNAs[J]. J Virol, 80, 5499-5508. doi: 10.1128/JVI.00200-06
Cui Y, Yu H, Zheng X, Peng R, Wang Q, Zhou Y, Wang R, Wang J, Qu B, Shen N, Guo Q, Liu X, Wang C, 2017: SENP7 potentiates cGAS activation by relieving SUMO-mediated inhibition of cytosolic DNA sensing[J]. PLoS Pathog, 13, e1006156-. doi: 10.1371/journal.ppat.1006156
Du T, Zhou G, Roizman B, 2011: HSV-1 gene expression from reactivated ganglia is disordered and concurrent with suppression of latency-associated transcript and miRNAs[J]. Proc Natl Acad Sci USA, 108, 18820-18824. doi: 10.1073/pnas.1117203108
Du T, Han Z, Zhou G, Roizman B, 2015: Patterns of accumulation of miRNAs encoded by herpes simplex virus during productive infection, latency, and on reactivation[J]. Proc Natl Acad Sci USA, 112, E49-55. doi: 10.1073/pnas.1422657112
Ebert MS, Sharp PA, 2010: MicroRNA sponges: progress and possibilities[J]. RNA, 16, 2043-2050. doi: 10.1261/rna.2414110
Ejercito PM, Kieff ED, Roizman B, 1968: Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells[J]. J Gen Virol, 2, 357-364. doi: 10.1099/0022-1317-2-3-357
Enk J, Levi A, Weisblum Y, Yamin R, Charpak-Amikam Y, Wolf DG, 2016: HSV1 MicroRNA modulation of GPI anchoring and downstream immune evasion[J]. Cell Rep, 17, 949-956. doi: 10.1016/j.celrep.2016.09.077
Flores O, Nakayama S, Whisnant AW, Javanbakht H, Cullen BR, Bloom DC, 2013: Mutational inactivation of herpes simplex virus 1 microRNAs identifies viral mRNA targets and reveals phenotypic effects in culture[J]. J Virol, 87, 6589-6603. doi: 10.1128/JVI.00504-13
Gregory D, Hargett D, Holmes D, Money E, Bachenheimer SL, 2004: Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway[J]. J Virol, 78, 13582-13590. doi: 10.1128/JVI.78.24.13582-13590.2004
Gu H, Roizman B, 2007: Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST-REST complex[J]. Proc Natl Acad Sci USA, 104, 17134-17139. doi: 10.1073/pnas.0707266104
Han Z, Liu X, Chen X, Zhou X, Du T, Roizman B, 2016: miR-H28 and miR-H29 expressed late in productive infection are exported and restrict HSV-1 replication and spread in recipient cells[J]. Proc Natl Acad Sci USA, 113, E894-901. doi: 10.1073/pnas.1525674113
Horwich MD, Zamore PD, 2008: Design and delivery of antisense oligonucleotides to block microRNA function in cultured drosophila and human cells[J]. Nat Protoc, 3, 1537-1549. doi: 10.1038/nprot.2008.145
Jiang X, Brown D, Osorio N, Hsiang C, BenMohamed L, Wechsler SL, 2016: Increased neurovirulence and reactivation of the herpes simplex virus type 1 latency-associated transcript (LAT)-negative mutant dLAT2903 with a disrupted LAT miR-H2[J]. J Neurovirol, 22, 38-49. doi: 10.1007/s13365-015-0362-y
Jurak I, Kramer MF, Mellor JC, van Lint AL, Roth FP, Knipe DM, 2010: Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2[J]. J Virol, 84, 4659-4672. doi: 10.1128/JVI.02725-09
Jurak I, Hackenberg M, Kim JY, Pesola JM, Everett RD, Preston CM, 2014: Expression of herpes simplex virus 1 microRNAs in cell culture models of quiescent and latent infection[J]. J Virol, 88, 2337-2339. doi: 10.1128/JVI.03486-13
Kim H, Iizasa H, Kanehiro Y, Fekadu S, Yoshiyama H, 2017: Herpesviral microRNAs in cellular metabolism and immune responses[J]. Front Microbiol, 8, 1318-. doi: 10.3389/fmicb.2017.01318
Kluiver J, Slezak-Prochazka I, Smigielska-Czepiel K, Halsema N, Kroesen BJ, van den Berg A, 2012: Generation of miRNA sponge constructs[J]. Methods, 58, 113-117. doi: 10.1016/j.ymeth.2012.07.019
Kramer MF, Jurak I, Pesola JM, Boissel S, Knipe DM, Coen DM, 2011: Herpes simplex virus 1 microRNAs expressed abundantly during latent infection are not essential for latency in mouse trigeminal ganglia[J]. Virology, 417, 239-247. doi: 10.1016/j.virol.2011.06.027
Kurata JS, Lin RJ, 2018: MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs[J]. RNA, 24, 966-981. doi: 10.1261/rna.066282.118
Liu Z, Sall A, Yang D, 2008: MicroRNA: an emerging therapeutic target and intervention tool[J]. Int J Mol Sci, 9, 978-999. doi: 10.3390/ijms9060978
Mallon S, Wakim BT, Roizman B, 2012: Use of biotinylated plasmid DNA as a surrogate for HSV DNA to identify proteins that repress or activate viral gene expression[J]. Proc Natl Acad Sci USA, 103, E3549-3557.
Martinez-Torres FJ, Völcker D, Dörner N, Lenhard T, Nielsen S, Haas J, Kiening K, Meyding-Lamadé U, 2007: Aquaporin 4 regulation during acute and long-term experimental Herpes simplex virus encephalitis[J]. J Neurovirol, 13, 38-46. doi: 10.1080/13550280601145340
McKnight JL, Kristie TM, Roizman B, 1987: Binding of the virion protein mediating alpha gene induction in herpes simplex virus 1-infected cells to its cis site requires cellular proteins[J]. Proc Natl Acad Sci USA, 84, 7061-7065. doi: 10.1073/pnas.84.20.7061
Munson DJ, Burch AD, 2012: A novel miRNA produced during lytic HSV-1 infection is important for efficient replication in tissue culture[J]. Arch Virol, 157, 1677-1688. doi: 10.1007/s00705-012-1345-4
Roizman B, Whitley RJ, 2013: An inquiry into the molecular basis of HSV latency and reactivation[J]. Annu Rev Microbiol, 67, 355-374. doi: 10.1146/annurev-micro-092412-155654
Roller RJ, Roizman B, 1992: The herpes simplex virus 1 RNA binding protein US11 is a virion component and associates with ribosomal 60S subunits[J]. J Virol, 66, 3624-3632.
Sun L, Li Q, 2012: The miRNAs of herpes simplex virus (HSV)[J]. Virol Sin, 27, 333-338.
Tay FC, Lim JK, Zhu H, Hin LC, Wang S, 2015: Using artificial microRNA sponges to achieve microRNA loss-of-function in cancer cells[J]. Adv Drug Deliv Rev, 81, 117-127. doi: 10.1016/j.addr.2014.05.010
Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM, Cullen BR, 2008: MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs[J]. Nature, 454, 780-783. doi: 10.1038/nature07103
Umbach JL, Nagel MA, Cohrs RJ, Gilden DH, Cullen BR, 2009: Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia[J]. J Virol, 83, 10677-10683. doi: 10.1128/JVI.01185-09
Wang S, Mott KR, Cilluffo M, Kilpatrick CL, Murakami S, Ljubimov AV, Kousoulas KG, Awasthi S, Luscher B, Ghiasi H, 2018: The absence of DHHC3 affects primary and latent herpes simplex virus 1 infection[J]. J Virol, 92, e01599-17.
Wu W, Guo Z, Zhang X, Guo L, Liu L, Liao Y, 2013: A microRNA encoded by HSV-1 inhibits a cellular transcriptional repressor of viral immediate early and early genes[J]. Sci China Life Sci, 56, 373-383. doi: 10.1007/s11427-013-4458-4
Yu X, He S, 2016: The interplay between human herpes simplex virus infection and the apoptosis and necroptosis cell death pathways[J]. Virol J, 13, 77-. doi: 10.1186/s12985-016-0528-0
Zhao H, Zhang C, Hou G, Song J, 2015: MicroRNA-H4-5p encoded by HSV-1 latency-associated transcript promotes cell proliferation, invasion and cell cycle progression via p16-mediated PI3 K-Akt signaling pathway in SHSY5Y cells[J]. Int J Clin Exp Med, 8, 7526-7534.